Search research articles
Contact Us
Filters
Showing results (71-80 of 146) with videos related to
Page
of 15
Sort By:
Critical Reviews in Oncology/Hematology
|
January 20, 2020
Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis
Ambica Parmar, Jorge Chaves-Porras, Ronak Saluja, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 10, 2018
Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel
Daniel W Yokom, John Stewart, Nimira S Alimohamed, et al.
American Journal of Clinical Oncology
|
December 1, 2005
A multicenter phase II study of "adjuvant" irinotecan following resection of colorectal hepatic metastases
Helen J Mackay, Kevin Billingsley, Steven Gallinger, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 25, 2016
Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone
Fred Saad, Eric Winquist, Stacey Hubay, et al.
Canadian Medical Education Journal
|
May 17, 2021
Ten ways to get a grip on designing and implementing a competency-based medical education training program
Tina Hsu, Flávia De Angelis, Sohaib Al-Asaaed, et al.
Pharmaceutical Statistics
|
August 6, 2013
Use of historical control data for assessing treatment effects in clinical trials
Kert Viele, Scott Berry, Beat Neuenschwander, et al.
Trials
|
March 23, 2023
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
Andre Schultz, Charlie McLeod, Scott Berry, et al.
The Lancet. Oncology
|
June 3, 2023
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study
Kristina Jenei, Adam J N Raymakers, Arnaud Bayle, et al.
Molecular Cell
|
December 12, 2024
CRL3<sup>ARMC5</sup> ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription
Roberta Cacioppo, Alexander Gillis, Iván Shlamovitz, et al.
The Oncologist
|
November 7, 2015
Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer
Urban Emmenegger, Christopher M Booth, Scott Berry, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 146) with videos related to
Sort By:
Page
of 15
Critical Reviews in Oncology/Hematology
|
January 20, 2020
Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis
Ambica Parmar, Jorge Chaves-Porras, Ronak Saluja, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 10, 2018
Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel
Daniel W Yokom, John Stewart, Nimira S Alimohamed, et al.
American Journal of Clinical Oncology
|
December 1, 2005
A multicenter phase II study of "adjuvant" irinotecan following resection of colorectal hepatic metastases
Helen J Mackay, Kevin Billingsley, Steven Gallinger, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 25, 2016
Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone
Fred Saad, Eric Winquist, Stacey Hubay, et al.
Canadian Medical Education Journal
|
May 17, 2021
Ten ways to get a grip on designing and implementing a competency-based medical education training program
Tina Hsu, Flávia De Angelis, Sohaib Al-Asaaed, et al.
Pharmaceutical Statistics
|
August 6, 2013
Use of historical control data for assessing treatment effects in clinical trials
Kert Viele, Scott Berry, Beat Neuenschwander, et al.
Trials
|
March 23, 2023
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
Andre Schultz, Charlie McLeod, Scott Berry, et al.
The Lancet. Oncology
|
June 3, 2023
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study
Kristina Jenei, Adam J N Raymakers, Arnaud Bayle, et al.
Molecular Cell
|
December 12, 2024
CRL3<sup>ARMC5</sup> ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription
Roberta Cacioppo, Alexander Gillis, Iván Shlamovitz, et al.
The Oncologist
|
November 7, 2015
Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer
Urban Emmenegger, Christopher M Booth, Scott Berry, et al.
Page
of 15